We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

130 hedge funds and large institutions have $40.7M invested in Sanofi Contingent Value Rights in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 136 → 130 (-6)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

88% less capital invested

Capital invested by funds: $338M → $40.7M (-$297M)

Holders
130
Holders Change
-6
Holders Change %
-4.41%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
26
Increased
24
Reduced
32
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$11.4M
2
CPM
Chesapeake Partners Management
Maryland
+$5.44M
3
MCM
Mason Capital Management
New York
+$4.18M
4
PWAM
Park West Asset Management
California
+$3.63M
5
SI
Standard Investments
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
DI
Dalton Investments
Nevada
-$34M
2
SC
Sculptor Capital
New York
-$24.1M
3
ACM
Abrams Capital Management
Massachusetts
-$23.6M
4
AC
Aristeia Capital
Connecticut
-$13.2M
5
AAA
Alpine Associates Advisors
New Jersey
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
MPWT
101
MassMutual Private Wealth & Trust
Connecticut
$5 +$17 +14 New
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
DI
103
Dalton Investments
Nevada
– -$34M -16,825,566 Closed
SC
104
Sculptor Capital
New York
– -$24.1M -11,930,969 Closed
AC
105
Aristeia Capital
Connecticut
– -$13.2M -6,548,815 Closed
AAA
106
Alpine Associates Advisors
New Jersey
– -$10.9M -5,421,000 Closed
NRC
107
North Run Capital
Massachusetts
– -$9.97M -4,933,961 Closed
AGC
108
Angelo Gordon & Co
New York
– -$6.98M -3,457,600 Closed
YCMGA
109
York Capital Management Global Advisors
New York
– -$6.41M -3,171,303 Closed
BHIA
110
Birch Hill Investment Advisors
Massachusetts
– -$3.68M -1,822,660 Closed
TA
111
TRB Advisors
New York
– -$3.08M -1,525,000 Closed
SA
112
Smithwood Advisers
California
– -$3.03M -1,500,000 Closed
HCM
113
Highbridge Capital Management
New York
– -$2.52M -1,250,000 Closed
FCM
114
Freshford Capital Management
New York
– -$1.86M -923,206 Closed
LCM
115
Lakewood Capital Management
New York
– -$1.25M -618,500 Closed
LOM
116
Loeb Offshore Management
New York
– -$976K -483,140 Closed
PCM
117
Pentwater Capital Management
Florida
– -$367K -181,700 Closed
ACM
118
American Capital Management
New York
– -$306K -151,420 Closed
LOAMU
119
Lombard Odier Asset Management (USA)
New York
– -$303K -150,000 Closed
Neuberger Berman Group
120
Neuberger Berman Group
New York
– -$200K -98,920 Closed
DMK
121
David M. Knott
– -$186K -92,000 Closed
TPM
122
T2 Partners Management
New York
– -$164K -81,100 Closed
WCM
123
Waterstone Capital Management
Minnesota
– -$143K -70,981 Closed
PCM
124
Prelude Capital Management
New York
– -$83K -41,200 Closed
DBG
125
De Burlo Group
Massachusetts
– -$81K -40,300 Closed
2 3 4
5
6

GCVRZ Hedge Fund Activity: Q4 2013 in Review

130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2013, worth a combined $40.7M — down 88% from $338M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of GCVRZ and 26 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $11.4M. The largest seller was Dalton Investments, exiting entirely with an estimated $34M sold.

  • 130 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2013, down from 136 in Q3 2013.
  • Funds reported $40.7M of Sanofi Contingent Value Rights stock for Q4 2013, down 88% quarter-over-quarter.
  • 26 funds opened new Sanofi Contingent Value Rights positions in Q4 2013 and 31 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2013 was Fir Tree Capital Management, an estimated $11.4M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2013 was Dalton Investments, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2013.